ATLANTA—Medical device maker CardioMEMS priced its planned initial public offering of six million shares of stock at $12 to $14 each.

In its Securities and Exchange Commission filing the company says it expects to net $70.6 million from the IPO.

It will trade on the NASDAQ exchange under the symbol “SENS.”

The company recently received U.S. Food and Drug Administration approval of its EndoSure wireless pressure measurement system, designed to measure blood pressure during aortic aneurysm repairs. The company’s wireless sensors provide bodily information, such as monitoring hearts, through minimally invasive means.

In November the company closed a mezzanine round of $22 million. Investors include Atlanta’s Arcapita, Boston Millennia Parnters, Easton Capital Parnters, Foundation Medical Partners, Medtronic and Johnson and Johnson Development Corp.

Founded in 2001, CardioMEMS, which is based at the Georgia Tech Advanced Technology Development Center, raised more than $50 million in venture capital.

Southeast Venture Conference, February 29 – March 1, 2012 at the Ritz Carlton in Tysons Corner, VA – Where Smart Money Meets Smart People.
www.seventure.org

© 2007, TechJournal South. All rights reserved.